{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:03:44Z","timestamp":1780031024362,"version":"3.53.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-026-01513-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:27:46Z","timestamp":1780028866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiopharmaceuticals for the Treatment of Chronic Cancer Pain"],"prefix":"10.1007","volume":"30","author":[{"given":"Ahmed I.","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn M","family":"Nytes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnabas T","family":"Shiferaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Abd-Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"11","key":"1513_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-021-01587-7","volume":"38","author":"R Kapoor","year":"2021","unstructured":"Kapoor R, Saxena A, Vasudev A, Sundriyal D, Kumar A. Cancer induced bone pain: current management and future perspectives. Med Oncol. 2021;38(11):1\u20137. This reference establishes the clinical burden of cancer induced bone pain and the limitations of conventional analgesic strategies, which provides the rationale for exploring radiopharmaceutical therapy.","journal-title":"Med Oncol"},{"issue":"2","key":"1513_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40487-020-00128-y","volume":"8","author":"KL Gress","year":"2020","unstructured":"Gress KL, Charipova K, Kaye AD, Viswanath O, Urits I. An Overview of Current Recommendations and Options for the Management of Cancer Pain: A Comprehensive Review. Oncol Ther. 2020;8(2):251\u20139. https:\/\/doi.org\/10.1007\/s40487-020-00128-y . Epub 2020 Sep 7. PMID: 32894414; PMCID: PMC7683745.","journal-title":"Oncol Ther"},{"issue":"7","key":"1513_CR3","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/curroncol30070500","volume":"30","author":"F Mestdagh","year":"2023","unstructured":"Mestdagh F, Steyaert A, Lavand\u2019homme P. Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques. Curr Oncol. 2023;30(7):6838\u201358.","journal-title":"Curr Oncol"},{"issue":"Suppl 3","key":"1513_CR4","first-page":"S1","volume":"7","author":"JR Gralow","year":"2009","unstructured":"Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar RN, et al. NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Cancer Netw JNCCN. 2009;7(Suppl 3):S1\u201332. quiz S33-35.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"1513_CR5","doi-asserted-by":"publisher","first-page":"113871","DOI":"10.1016\/j.biopha.2022.113871","volume":"156","author":"CG Virgen","year":"2022","unstructured":"Virgen CG, Kelkar N, Tran A, Rosa CM, Cruz-Topete D, Amatya S, Cornett EM, Urits I, Viswanath O, Kaye AD. Pharmacological management of cancer pain: Novel therapeutics. Biomed Pharmacother. 2022;156:113871. https:\/\/doi.org\/10.1016\/j.biopha.2022.113871 . Epub 2022 Oct 19. PMID: 36272265.","journal-title":"Biomed Pharmacother"},{"key":"1513_CR6","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2147\/JPR.S315585","volume":"14","author":"MM Aman","year":"2021","unstructured":"Aman MM, Mahmoud A, Deer T, Sayed D, Hagedorn JM, Brogan SE, et al. The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain. J Pain Res. 2021;142139\u201364.<\\\/p>","journal-title":"J Pain Res"},{"issue":"1","key":"1513_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40487-021-00149-1","volume":"9","author":"J Watson","year":"2021","unstructured":"Watson J, Ninh MK, Ashford S, Cornett EM, Kaye AD, Urits I, Viswanath O. Anesthesia Medications and Interaction with Chemotherapeutic Agents. Oncol Ther. 2021;9:(1):121\u201338. https:\/\/doi.org\/10.1007\/s40487-021-00149-1. Epub 2021 Apr 16. PMID: 33861416; PMCID: PMC8140172.","journal-title":"Oncol Ther"},{"key":"1513_CR8","doi-asserted-by":"crossref","unstructured":"Jong JM, van Oprea-Lager D, Hooft DE, de Klerk L, Bloemendal JMH, Verheul HJ et al. HMW,. Radiopharmaceuticals for palliation of bone pain in patients with castration-resistant prostate cancer metastatic to bone: A systematic review. Eur Urol. 2016;70(3):416\u201326. ** This systemic review syntehsizes comparitive clincial evidence for radipharmceuticls, hich reinforces the papers discussion of treatment selection, benefits, and limitiations in advanced prostate cancer.","DOI":"10.1016\/j.eururo.2015.09.005"},{"issue":"1","key":"1513_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","volume":"10","author":"S Zhang","year":"2025","unstructured":"Zhang S, Wang X, Gao X, Chen X, Li L, Li G, et al. Radiopharmaceuticals and their applications in medicine. Signal Transduct Target Ther. 2025;10(1):1\u201351.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"1513_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/oncolo\/oyac279","volume":"28","author":"B Ramnaraign","year":"2023","unstructured":"Ramnaraign B, Sartor O. PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials. Oncologist. 2023;28(5):392\u2013401.","journal-title":"Oncologist"},{"key":"1513_CR11","doi-asserted-by":"crossref","unstructured":"Paes FM, Serafini AN. Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain. Semin Nucl Med. 2010;40(2):89\u2013104. ** This reference provides the core mechanistic and clinical framework for beta emitting radiopharmaceuticals, which supports multiple efficacy and uptake claims throughout this paper.","DOI":"10.1053\/j.semnuclmed.2009.10.003"},{"issue":"1","key":"1513_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10585-016-9831-9","volume":"34","author":"T Das","year":"2017","unstructured":"Das T, Banerjee S. Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons. Clin Exp Metastasis. 2017;34(1):1\u201310.","journal-title":"Clin Exp Metastasis"},{"issue":"8","key":"1513_CR13","first-page":"1358","volume":"45","author":"N Pandit-Taskar","year":"2004","unstructured":"Pandit-Taskar N, Batraki M, Divgi CR. Radiopharmaceutical Therapy for Palliation of Bone Pain from Osseous Metastases. J Nucl Med. 2004;45(8):1358\u201365.","journal-title":"J Nucl Med"},{"key":"1513_CR14","doi-asserted-by":"crossref","unstructured":"Ogawa K, Ishizaki A. Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases. BioMed Res Int. 2015:676053.","DOI":"10.1155\/2015\/676053"},{"issue":"3","key":"1513_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1213755","volume":"369","author":"C Parker","year":"2013","unstructured":"Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Foss\u00e5 SD, et al. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer. N Engl J Med. 2013;369(3):213\u201323. This is a important phase 3 ALSYMPCA trial that provides evidence that radium-223 not only provides pain palliation but also improves overall survival, forming the strongest clinical justification for alpha emitting radiopharmaceuticals in metastatic bone disease.","journal-title":"N Engl J Med"},{"issue":"5","key":"1513_CR16","first-page":"678","volume":"48","author":"S Nilsson","year":"2012","unstructured":"Nilsson S, Strang P, Aksnes AK, Franz\u00e8n L, Olivier P, Pecking A, et al. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur J Cancer Oxf Engl 1990. 2012;48(5):678\u201386.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"1","key":"1513_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00259-014-2862-z","volume":"42","author":"KK Agarwal","year":"2015","unstructured":"Agarwal KK, Singla S, Arora G, Bal C. (177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study. Eur J Nucl Med Mol Imaging. 2015;42(1):79\u201388. https:\/\/doi.org\/10.1007\/s00259-014-2862-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1513_CR18","unstructured":"World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents [Internet]. Geneva: World Health Organization. 2018 [cited 2025 Mar 4]. 138 p. Available from: https:\/\/iris.who.int\/handle\/10665\/279700"},{"issue":"8","key":"1513_CR19","first-page":"3133","volume":"27","author":"G Allano","year":"2019","unstructured":"Allano G, George B, Minello C, Burnod A, Maindet C, Lemaire A. Strategies for interventional therapies in cancer-related pain\u2014a crossroad in cancer pain management. Support Care Cancer. 2019;27(8):3133\u201345.","journal-title":"Support Care Cancer"},{"issue":"30","key":"1513_CR20","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1200\/JCO.2013.54.8404","volume":"32","author":"E Basch","year":"2014","unstructured":"Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, et al. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(30):3436\u201348.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"1513_CR21","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1177\/1060028014545644","volume":"48","author":"RN Dansereau","year":"2014","unstructured":"Dansereau RN. A unique drug distribution process for radium Ra 223 dichloride injection and its implication for product quality, patient privacy, and delineation of professional responsibilities. Ann Pharmacother. 2014;48(11):1512\u20134.","journal-title":"Ann Pharmacother"},{"key":"1513_CR22","doi-asserted-by":"publisher","first-page":"112503","DOI":"10.1016\/j.biopha.2021.112503","volume":"146","author":"J Zeien","year":"2022","unstructured":"Zeien J, Qiu W, Triay M, Dhaibar HA, Cruz-Topete D, Cornett EM, Urits I, Viswanath O, Kaye AD. Clinical implications of chemotherapeutic agent organ toxicity on perioperative care. Biomed Pharmacother. 2022;146:112503. https:\/\/doi.org\/10.1016\/j.biopha.2021.112503. Epub 2021 Dec 15. PMID: 34922113; PMCID: PMC11118057.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1513_CR23","first-page":"268","volume":"55","author":"N Pandit-Taskar","year":"2014","unstructured":"Pandit-Taskar N, Larson SM, Carrasquillo JA. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: \u03b1 therapy with 223Ra-dichloride. J Nucl Med Off Publ Soc Nucl Med. 2014;55(2):268\u201374.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"3","key":"1513_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/jpm.1998.1.277","volume":"1","author":"RS Hellman","year":"1998","unstructured":"Hellman RS, Krasnow AZ. Radionuclide therapy for palliation of pain due to osteoblastic metastases. J Palliat Med. 1998;1(3):277\u201383.","journal-title":"J Palliat Med"},{"issue":"10","key":"1513_CR25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Ta\u00efeb","year":"2019","unstructured":"Ta\u00efeb D, Hicks RJ, Hindi\u00e9 E, Guillet BA, Avram A, Ghedini P, et al. European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019;46(10):2112\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01513-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01513-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01513-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:27:49Z","timestamp":1780028869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01513-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01513-4","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alan D Kaye is the Editor-in-Chief for CPHRs. Alaa Abd-Elsayed is the section editor for CPHRs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article is based on previous studies and contains no new studies with human participants or animals performed by any authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Guidelines"}}],"article-number":"78"}}